Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription 17.08.2026 2 Am J Respir Cell Mol Biol 1 Arerugi 4 Chest 1 J Allergy Clin Immunol 3 Pediatr Allergy Immunol 1 Pediatr Pulmonol 2 Pediatrics 16 Respir Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Cell Mol Biol

1. PENN RB
   GPCR Biology-Informed Drug Discovery in Asthma.
   Am J Respir Cell Mol Biol. 2026 Aug 14:aanag168. doi: 10.1093.
   PubMed         Abstract available
   
   
2. PRAKASH YS
   Blast These Dying Fibroblasts in Asthma.
   Am J Respir Cell Mol Biol. 2026 Aug 8:aanag160. doi: 10.1093.
   PubMed        
   
   

   
   Arerugi

3. OSANAI S, Minami Y, Sasaki T
   [CHARACTERISTICS OF ASTHMA PATIENTS WITH A FORCED EXPIRATORY VOLUME IN ONE SECOND/FORCED VITAL CAPACITY OF LESS THAN 70% IN A BRONCHODILATOR INHALATION TEST].
   Arerugi. 2026;75:297-304.
   PubMed         Abstract available
   
   

   
   Chest

4. CHAN ED
   Comparison of Antiinflammatory Therapies for Bronchiectasis.
   Chest. 2026;170:e59-e60.
   PubMed        
   
   
5. ELDEIRY D, Geyer A, Machnicki S
   A Case of Progressively Worsening Dyspnea and Chronic Cough in a Patient With Known Bronchiectasis.
   Chest. 2026;170:e35-e38.
   PubMed         Abstract available
   
   
6. CHANDRA D
   Not All Emphysema Is Equal: Centrilobular Subtype as a Window Into Cardiovascular Risk.
   Chest. 2026;170:287-289.
   PubMed        
   
   
7. LIN CY, Zhong BK, Chou YT, Kuo CW, et al
   Eosinophilic Versus Non-Eosinophilic Acute Exacerbations of COPD and Subsequent Cardiovascular Event.
   Chest. 2026 Apr 1:S0012-3692(26)00432-0. doi: 10.1016/j.chest.2026.
   PubMed         Abstract available
   
   

   
   J Allergy Clin Immunol

8. BECKER PM, Fulkerson PC, Togias A
   The importance of early life cohort studies for understanding the origins of asthma and allergic diseases and the contribution of NIAID.
   J Allergy Clin Immunol. 2026 Aug 10:S0091-6749(26)00563.
   PubMed        
   
   

   
   Pediatr Allergy Immunol

9. LISIK D, Lin Q, Russo MD, Goksor E, et al
   Unhealthy food consumption and asthma in children and adolescents.
   Pediatr Allergy Immunol. 2026;37:e70460.
   PubMed        
   
   
10. GONZALEZ-URIBE V, Prieto-Gomez J, Moreno-Castro S, Martinez-Tenopala R, et al
    Early and longitudinal response to sublingual immunotherapy across pediatric allergic multimorbidity patterns: A 3-year real-world cohort study.
    Pediatr Allergy Immunol. 2026;37:e70462.
    PubMed         Abstract available
    
    
11. YILMAZ E, Ozer NK, Topal E
    Comment on: Bronchodilator response is linked with uncontrolled moderate-to-severe childhood asthma and elevated IL-4 and IL-13.
    Pediatr Allergy Immunol. 2026;37:e70443.
    PubMed        
    
    

    
    Pediatr Pulmonol

12. FORSSTROM V, Waris M, Peltola V, Toivonen L, et al
    Rhinovirus Species in Acute Respiratory Tract Infections and the Risk of Asthma in Children.
    Pediatr Pulmonol. 2026;61:e71782.
    PubMed         Abstract available
    
    

    
    Pediatrics

13. KENYON CC, Negro D, Fluehr J, Shults J, et al
    Asthma Exacerbation Risk and School Asthma Readiness.
    Pediatrics. 2026 Aug 10:e2025074267. doi: 10.1542/peds.2025-074267.
    PubMed         Abstract available
    
    
14. BRUNNER WM, Kjolhede C
    Preparing for School Asthma Readiness.
    Pediatrics. 2026 Aug 10:e2026077133. doi: 10.1542/peds.2026-077133.
    PubMed        
    
    

    
    Respir Med

15. MENG T, Zhang X, Bao Y, Maihemuti M, et al
    Differential expression of succinylation in lung mitochondria of patients with chronic obstructive pulmonary disease and its correlation with oxidative stress.
    Respir Med. 2026;261:108949.
    PubMed         Abstract available
    
    
16. KANG HR, Song JH, Park S, Ra SW, et al
    Divergent prognostic roles of air trapping and reduced inspiratory reserve in COPD: Exacerbations versus functional decline.
    Respir Med. 2026;261:108978.
    PubMed         Abstract available
    
    
17. QUARANTA VN, Dragonieri S, Cosentino G, Motta V, et al
    Should triple inhaled therapy be initiated earlier in the disease course of COPD to modify long-term outcomes, including mortality, exacerbations, and cardiovascular risk?
    Respir Med. 2026;261:108965.
    PubMed         Abstract available
    
    
18. MIAO C, Feng S, Wang F, Yang Y, et al
    Quantitative CT-Derived extrapulmonary body composition and the risk of acute exacerbations in COPD: A prospective cohort study.
    Respir Med. 2026;261:108992.
    PubMed         Abstract available
    
    
19. CAMARGO PF, Back GD, Carvalho LCS -Jr, Areas GPT, et al
    The hidden burden of overlap syndrome: Sleep quality and functional impairment in chronic obstructive pulmonary disease.
    Respir Med. 2026;261:109000.
    PubMed         Abstract available
    
    
20. PASTORINO L, Ferraris M, Robbiano M, Staffiere C, et al
    Targeting the neutrophil-DPP-1-protease axis in airway disease: current evidence and future indications.
    Respir Med. 2026;261:109006.
    PubMed         Abstract available
    
    
21. YANG X, Wang X
    Irisin in airway remodeling in COPD: Regulatory mechanisms from epithelial barrier to smooth muscle.
    Respir Med. 2026;261:109020.
    PubMed         Abstract available
    
    
22. WAN Q, Deng Z, Wu F, Zhou K, et al
    The longitudinal decrease in exercise tolerance and disease progression in mild-to-moderate COPD.
    Respir Med. 2026;261:109021.
    PubMed         Abstract available
    
    
23. GUNES M, Avci RH
    Respiratory muscle strength, functional exercise capacity, and muscle oxygenation differences between COPD, PRISM, and healthy controls.
    Respir Med. 2026;261:109024.
    PubMed         Abstract available
    
    
24. SURAPRAPAPICH P, Watanapa WB, Dacha S, Ketpan W, et al
    Eight-week high-intensity inspiratory muscle training improves cardiac autonomic function in COPD: a randomized controlled trial.
    Respir Med. 2026;261:109027.
    PubMed         Abstract available
    
    
25. RASMUSSEN DB, Meteran H, Lamberts M, Torp-Pedersen C, et al
    Beta-blockers and mortality after myocardial infarction in patients with and without chronic obstructive pulmonary disease - A Danish nationwide cohort study of 96,567 patients.
    Respir Med. 2026;261:109023.
    PubMed         Abstract available
    
    
26. QAISAR R, Khan IU, Karim A, Ahmad F, et al
    Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease.
    Respir Med. 2026;261:109040.
    PubMed         Abstract available
    
    
27. DOO JH, Yu J, Park SJ, Park SW, et al
    Smoking cessation and depression risk in newly diagnosed COPD patients: A nationwide cohort study.
    Respir Med. 2026;261:109050.
    PubMed         Abstract available
    
    
28. GUO X, Luo Q, Chen D, Lin H, et al
    Association between vigorous-intensity work activities and cough or expectoration symptoms in individuals with mild to moderate COPD: a cross-sectional study using the NHANES database.
    Respir Med. 2026;261:109055.
    PubMed         Abstract available
    
    
29. FIDLER LM, Arbiv OA, Fisher JH, Shapera S, et al
    Impact of obstructive lung disease on survival in patients with rheumatoid arthritis related interstitial lung disease.
    Respir Med. 2026;261:109070.
    PubMed         Abstract available
    
    
30. MIAO X, Han Y, Jin X, Wu Z, et al
    Latent profile analysis of breathlessness catastrophizing in patients with chronic obstructive pulmonary disease.
    Respir Med. 2026;261:109074.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum